Online View
|
|
AI-Driven Antibody Discovery
with Cell-Free Expression From in silico design to functional Abs in just days.
|
|
Accelerate antibody discovery with our cell-free protein synthesis platform (CFPS)—ideal for AI and computational biology teams. Sino Biological has developed a high-yield, E. coli-based lysate platform enabling rapid scFv and VHH expression without transfection or culturing. Go from in silico design to functional antibodies in days. We synthesize, express, purify, and validate AI-generated sequences through ELISA and BLI, ensuring specificity and detailed binding data. Cell-free expression also can overcome cellular limitations, making it possible to produce toxic or difficult-to-express targets. Let us handle the wet lab while you drive innovation—streamlining your path from sequence to insight.
|
Partner with Us for Faster, Smarter Discovery 
|
How Cell-Free Expression Platform Supports AI Discovery
|

|
Antibody developability package available: aggregation, poly-reactivity, thermostability, self-association, hydrophobicity, colloidal stability, cross-interaction, cell-based assay
|
|
Highlights of Cell-Free Expression Platform
|

|
Fast and efficient
synthesis completed in just 3-5 hours
|
|

|
High success rate
>99% success rate
|

|
Consistency
comparable activity to proteins expressed in mammalian cells
|
|

|
High throughput
>2,000/project
|
|
Case Studies
|
|
VHH Synthesized by CFPS with Comparable Binding Activity as that Expressed in Mammalian Cells
|
|
Anti-IL6R VHH Binding (ELISA)
|

|
Anti-TROP2 VHH Binding (ELISA)
|

|
|
|
HTP scFv-His/VHH-His Synthesis for AI Screening
|
|
Format: 2000+ scFv-His and VHH-His antibodies
Expression system: CFPS
Target: Finished expression and affinity analysis with different target proteins by BLI
Timeline: 3-4 weeks
|
Reducing SDS-PAGE
|

|
BLI Assay
|

|
SEC-HPLC
|

|
|
|
|
Don’t Miss Out!
|

Kinase Drug Discovery Solutions >>
|

Center for Bioprocessing (C4B)
US-Based Recombinant Production >>
|
|
|
|